Lung lesions caused by vaping: new challenges and new solutions (literature review)
https://doi.org/10.51793/OS.2022.25.10.001
Abstract
The modern world constantly presents us with unusual challenges. One of the new trends should include electronic cigarettes and vapes, which are firmly embedded in the ubiquitous environment of young people, including minors. In recent years, reports of cases of lung lesions associated with their use, as well as outbreaks of this new pathology, have become increasingly frequent. The article structures foreign and Russian data concerning a new pathology associated with the use of vaping. Clinical forms from exposure to electronic cigarettes can be represented by both acute lung injury (acute pneumonitis, acute respiratory distress syndrome) and a fibrous process (organizing pneumonia, respiratory bronchiolitis). The difficulties of diagnosis are caused, on the one hand, by an underestimation of the current epidemiological situation associated with vaping, on the other – by the absence of pathognomonic symptoms characteristic of EVALI. Differential diagnosis should include a wide range of diseases. Significant difficulties in verifying vape-associated lesions may occur during the rise in the incidence of influenza and COVID-19, both of which may manifest similarly or even simultaneously with EVALI. Lung damage associated with the use of vapes is essentially a diagnosis of exclusion. Therapeutic approaches are not standardized and are rather scarce. According to the literature, the basis of treatment is respiratory support, pharmacotherapy does not have a broad evidence base. In the domestic general medical practice, one should pay more attention to the collection of anamnesis, especially in young people with respiratory and gastroenterological manifestations, indicating the fact of using vapes during the survey. The focus of primary care physicians and the subsequent implementation of a publicly available diagnostic algorithm will allow for the diagnosis of EVALI in a shorter time. In the future, we will continue to study this pathology and search for more specific manifestations of it.
About the Authors
L. Yu. PalmovaRussian Federation
Lyubov Yu. Palmova, MD, Associate professor of the Department of internal medicine
49 Butlerova str., Kazan, 420012
A. R. Zinnatullina
Russian Federation
Aigul R. Zinnatullina, assistant of the Department of internal medicine
49 Butlerova str., Kazan, 420012
E. V. Kulakova
Russian Federation
Ekaterina V. Kulakova, student
49 Butlerova str., Kazan, 420012
References
1. Belok S. H., Parikh R., Bernardo J. et al. E-cigarette, or vaping, product use-associated lung injury: a review. Pneumonia. 2020; 33 (6): 657-663.
2. Мамченко М. М., Скворцова Е. С. Электронные сигареты в современном мире. Информационно-просветительская брошюра М.: РИ О ЦН ИИОИЗ М3 РФ, 2019 г. 20 стр. [Mamchenko M. M., Skvortsova E.S. Electronic cigarettes in the modern world. Information and educational brochure M.: RI O CN IIOIZ M3 RF, 2019 g. 20 str.]
3. Отчет о научно-исследовательской работе по теме: «Проведение исследований рынка новых видов никотинсодержащей продукции, международной практики правового регулирования обращения такой продукции и разработка предложений по установлению в рамках Евразийского экономического союза обязательных требований к новым видам никотинсодержащей продукции и рекомендаций по механизмам их реализации» (промежуточный). 1 этап «Анализ основных видов никотиносодержащей продукции, международного опыта и практики ее регулирования». / Федеральное государственное бюджетное научное учреждение «Всероссийский научно-исследовательский институт табака, махоркии табачных изделий» (ФГБНУ ВНИИТТИ); руководитель НИР : заместитель директора по научной работе и инновациям ФГБНУ ВНИИТТИ Е. В. Ганучих. Краснодар, 2018. 217 с. [Report on research work on the topic: «Conducting market research of new types of nicotine-containing products, international practice of legal regulation of the circulation of such products and developing proposals to establish mandatory requirements for new types of nicotine-containing products within the framework of the Eurasian Economic Union and recommendations on mechanisms for their implementation» (interim). Stage 1 «Analysis of the main types of nicotine-containing products, international experience and practice of its regulation»/ Federal State Budgetary Scientific Institution «Vserossijskij nauchno-issledovatel'skij institut tabaka, mahorkii tabachnyh izdelij» (FSBSI VNIITTI); head of research: Deputy Director for Research and Innovation of FSBSI VNIITTI E. V. Ganuchih. Krasnodar, 2018. 217 s.]
4. Врачи Морозовской больницы спасли подростка, впервые в стране установив диагноз «легочное повреждение электронными сигаретами» 17.06.2021. / Морозовская ДГКБ ДЗМ [Electronic resource]. http://мороздгкб.рф/vrachi-morozovskoy-bolnitsy-spasli-podrostka-vpervyyev-strane-ustanoviv-diagnoz-legochnoye-povrezhdeniye-elektronnymisigaretami/ [Doctors of the Morozov hospital saved a teenager, for the first time in the country having established a diagnosis of «lung damage by electronic cigarettes» 17.06.2021. / Morozovskaya DGKB DZM [Electronic resource]. http://morozdgkb.rf/vrachi-morozovskoy-bolnitsy-spasli-podrostka-vpervyyev-strane-ustanoviv-diagnoz-legochnoye-povrezhdeniyeelektronnymisigaretami/]
5. Kichloo A., Khan A., Siddiqui N. et al. Habit mimics the illness: EVALI during the era of the COVID-19 pandemic // Journal of Investigative Medicine High Impact Case Reports. 2020; 8: 2324709620972243.
6. King B. A., Jones Ch. M., Baldwin G. T. et al. // The New England Journal of Medicine. 2020; 382: 689-691.
7. Werner A. K., Koumans E. H., Chatham-Stephens K. et al. Hospitalizations and deaths associated with EVALI // The New England Journal of Medicine. 2020; 382 (17): 1589-1598.
8. Kazachkov M., Pirzada M. Diagnosis of EVALI in the COVID-19 era. // The Lancet Respiratory Medicine. 2020; 8 (12): 1169-1170.
9. Ayoub M., Quamme M., Abdel-Reheem A. K. et al. COVID or Not COVID? A great mimicker behind the smoke screen // Cureus. 2021; 13 (11): e19480.
10. Modi S., Sangani R., Alhajhusain A. Acute lipoid pneumonia secondary to E-cigarettes use: an unlikely replacement for cigarettes // Chest. 2015; 148 (4): 382A.
11. Wu D., O’Shea D. F. Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate // Proceedings of the National Academy of Sciences. 2020; 117 (12): 6349-55.
12. Jensen P., Luo W., Pankow J. F.et al. Hidden formaldehyde in e-cigarette aerosols // The New England Journal of Medicine. 2015; 372 (4).
13. Adkins S. H., Anderson K. N., Goodman A. B. et al. Demographics, substance use behaviors, and clinical characteristics of adolescents with e-cigarette, or vaping, product use-associated lung injury (EVALI) in the United States in 2019 // Journal of the American Medical Association Pediatrics. 2020; 174 (7): e200756.
14. Garcia J. Vaping-associated lung injury riskier for older patients // Medscape Medical News. 2020.
15. Aldy K., Dazhe J. C., Madison M. et al. E-cigarette or vaping product useassociated lung injury (EVALI) features and recognition in the emergency department // Journal of the American College of Emergency Physicians Open. 2020; 1 (5): 1090-1096.
16. Siegel D. A., Jatlaoui T. C., Koumans E. H. et al. Update: interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung injury — United States // Morbidity and Mortality Weekly Report. 2019; 19 (12): 3420-3428.
17. Layden J. E., Ghinai I., Pray I. et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin – final report // The New England Journal of Medicine. 2020; 382 (10): 903-916.
18. Aberegg S. K., Maddock S. D., Blagev D. P. et al. Diagnosis of EVALI: General Approach and the Role of Bronchoscopy // Chest. 2020; 158 (2): 820-827.
19. Schier J. G., Meiman J. G., Layden J. et al. Severe pulmonary disease associated with electronic-cigarette-product use – interim guidance // Morbidity and Mortality Weekly Report. 2019; 68 (36): 787-790.
20. Layden J. E., Ghinai I., Pray I. et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin – Final Report // The New England Journal of Medicine. 2020; 382 (10): 903-916.
Review
For citations:
Palmova L.Yu., Zinnatullina A.R., Kulakova E.V. Lung lesions caused by vaping: new challenges and new solutions (literature review). Lechaschi Vrach. 2022;1(10):6-10. (In Russ.) https://doi.org/10.51793/OS.2022.25.10.001
JATS XML



















